We investigated 31 slabs (up to 20 × 10 × 5 mm) of extrahepatic cholangiocarcinoma from patients who underwent surgical resection at the Johns Hopkins Hospital or at the Asan Medical Center. Approval of the relevant institutional review boards was obtained. Twenty-nine samples were obtained at Johns Hopkins Hospital, and two were from the Asan Medical Center. Patients who received neoadjuvant chemotherapy or neoadjuvant radiation therapy were excluded.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.